H. Fukuzawa et al. / Journal of Organometallic Chemistry 696 (2011) 3643e3648
3647
dropwise to a mixture of N,O-dimethylhydroxylamine hydrochlo-
ride (5.36 g, 55 mmol) and butyryl chloride (5.19 mL, 50 mmol) in
CH2Cl2 (150 mL) at 0 ꢀC under argon. The reaction mixture was
warmed up to room temperature and stirred for 2 h. The solvent
was evaporated to give a white solid, to which a saturated brine and
a 1:1 mixture of Et2O/CH2Cl2 were added for extraction. The
aqueous layer was further extracted by a 1:1 mixture of Et2O/
CH2Cl2 three times. The combined organic layer was dried over
MgSO4, filtered, and the solvent was evaporated to dry. Purification
by flash column chromatography (eluent: hexane/ethyl
acetate ¼ 1:1) afforded 1a (3.89 g, 29.7 mmol) as a colorless oil in
59% yield. Spectral data were consistent with those reported
previously [26].
mixture of NaHCO3 (1.26 g, 15 mmol) and N-methylhydroxylamine
hydrochloride (0.42 g, 5.0 mmol) and the solution was vigorously
stirred. Butyryl chloride (0.52 mL, 5.0 mmol) was added dropwise
to the reaction mixture at 0 ꢀC, and then the mixture was stirred at
room temperature for 3 h. The organic layer was separated, and the
aqueous layer was acidified with AcOH and was extracted with
Et2O three times. The combined organic layer was dried over
MgSO4, filtered, and the solvent was evaporated to dry. Purification
by flash column chromatography (eluent: hexane/ethyl
acetate ¼ 2:1) afforded 1g (0.35 g, 3.0 mmol) as a colorless oil in
60% yield. Spectral data were consistent with those reported
previously [31]. Compounds 1h and 1i were prepared in the same
manner.
Compounds 1bed and 3a,b were prepared in the same manner,
and the spectral data for N-methyl-N-methoxypivalamide (1b) [27],
N-methyl-N-methoxybenzamide (1c) [28], N-methyl-N-methox-
ycrotonamide (3a) [29] and N-methyl-N-methoxycinnamamide
(3b) [30] were in accordance with those in the literature.
4.4.1. N-Phenyl-N-hydroxybutyramide (1h)
Colorless plate crystal. IR spectrum (ATR): 3171, 2958,
1626 cmꢁ1 1H NMR (CDCl3, 400 MHz):
. d 8.95 (br s, 1H, OH),
7.47e7.32 (m, 5H, arom.), 2.28 (br s, 2H, CH2CO), 1.72e1.61 (m, 2H,
CH2), 0.89 (t, J ¼ 7.6 Hz, 3H, CH3). 13C NMR (CDCl3, 100 MHz):
d 168.5
4.2.1. N-Methoxybutyramide (1d)
(C]O), 138.4 (ipso-C of Ph), 129.2 (Ph), 126.7 (Ph), 126.6 (Ph), 34.2
(CH2CO), 18.7 (CH2), 13.7 (CH3). Anal. Calcd for C10H13NO: C, 67.02;
H, 7.31; N, 7.82. Found: C, 66.67; H, 7.27; N, 7.71.
Colorless oil. IR spectrum (ATR): 3195, 2967, 1661, 1519,
1057 cmꢁ1. 1H NMR (CDCl3, 300 MHz):
d 9.98 (br s, 1H, NH), 3.67 (s,
3H, OCH3), 2.04 (br t, J ¼ 6.9 Hz, 2H, CH2CO), 1.66e1.54 (m, 2H, CH2),
0.88 (t, J ¼ 7.2 Hz, 3H, CH3). 13C NMR (CDCl3, 75 MHz):
d
171.0 (C]
4.4.2. N-Hydroxybutyramide (1i)
O), 63.9 (NOCH3), 34.8 (eCH2COe),18.8 (CH2),13.5 (CH3). MS (EI) m/
Pale yellow oil. IR spectrum (ATR): 3224, 2967, 1645 cmꢁ1
.
1H
z 117 (Mþ).
NMR (CDCl3, 300 MHz):
d 8.34 (br s, 1H), 3.49 (s, 1H), 2.13 (t,
J ¼ 7.3 Hz, 2H, CH2CO),1.71e1.64 (m, 2H, CH2), 0.95 (t, J ¼ 7.3 Hz, 3H,
4.3. Preparation of N-benzyloxyamide 1e and N-isopropoxyamide
1f
CH3). 13C NMR (CDCl3, 75 MHz):
(CH2), 13.5 (CH3).
d 171.8 (C]O), 34.8 (CH2CO), 18.8
A
procedure for N-methyl-N-benzyloxybutyramide (1e) is
4.5. General procedure for ruthenium-catalyzed reduction of
N-alkoxy- and N-hydroxyamides
representative. solution of N-methyl-N-hydroxybutyramide
A
(1.00 mL, 8.3 mmol), anhydrous K2CO3 (1.52 g, 11 mmol) and benzyl
bromide (1.31 mL, 11 mmol) in dry acetone (25 mL) was stirred for
12 h at 75 ꢀC under argon. The solvent was evaporated and the
residue was dissolved in CH2Cl2 and washed with a 1 M solution of
NaOH. The two layers were separated and the aqueous layer was
extracted three times with CH2Cl2. The combined organic layer was
dried over MgSO4, filtered and the solvent was evaporated to dry.
Purification by flash column chromatography (eluent: hexane/ethyl
acetate ¼ 10:1) afforded 1e (1.35 g, 6.51 mmol) as a colorless oil in
79% yield. Compound 1f was prepared in the same manner.
RuCl3$3H2O (6.5 mg, 0.025 mmol) and ZneCu couple (9.8 mg,
0.15 mmol) were placed in a glass Schlenk tube which was filled
with argon. Dibenzyl ether (90 mL, 0.47 mmol, internal standard), an
N-alkoxy- or N-hydroxyamide (0.50 mmol), and dehydrated EtOH
(1.0 mL) were added to the mixture in this order, and the reaction
mixture was refluxed at 100 ꢀC (bath temperature). The reaction
was followed by 1H NMR spectroscopy. NMR sample solutions were
prepared by sampling the reaction mixture (0.2 mL) which was
quenched under air and was mixed with CDCl3 (0.5 mL). Conver-
sions of substrates and yields of products were calculated based on
the ratio of integral areas for substrates and products relative to
that for the internal standard.
4.3.1. N-Methyl-N-benzyloxybutyramide (1e)
Colorless oil. IR spectrum (ATR): 2963, 1667, 1456, 1386 cmꢁ1. 1H
NMR (CDCl3, 300 MHz):
d
7.38e7.34 (m, 5H, arom.), 4.81 (s, 2H,
For isolation of the products, the reaction mixture was filtered to
remove insoluble materials. After removal of the solvent under
vacuum, the residue was extracted with ethyl acetate, and the
extract was filtered again to remove insoluble materials. The filtrate
was evaporated to dry, and purification by flash column chroma-
tography (eluent: hexane/ethyl acetate) afforded the products.
Spectral data for N-methylbutyramide (2a) [32], N-methyl-
pivalamide (2b) [32,33], N-methylbenzamide (2c) [34], butyramide
(2d) [35], N-phenylbutyramide (2e) [36], N-methyl-3-phenyl-
propanamide (2f) [37] and N-methylcinnamamide (4b) [38] were
consistent with those reported previously.
NOCH2Ph), 3.18 (s, 3H, NCH3), 2.35 (t, J ¼ 7.5 Hz, 2H, CH2CO),
1.67e1.54 (m, 2H, CH2), 0.90 (t, J ¼ 7.5 Hz, 3H, CH3). 13C NMR (CDCl3,
75 MHz):
d 175.1 (C]O), 134.6 (Ph), 129.2 (Ph), 128.9 (Ph), 128.7
(Ph), 76.2 (NOCH2Ph), 34.1 (eCH2COe), 34.0 (NCH3), 18.0 (CH2), 13.9
(CH3). MS (ESI) m/z 230.1 (M þ Naþ).
4.3.2. N-Methyl-N-isopropoxybutyramide (1f)
Colorless oil. IR spectrum (ATR): 2974, 1669, 1383, 1112 cmꢁ1
.
1H NMR (CDCl3, 300 MHz):
d 4.14e4.06 (m, 1H, NOCH(CH3)2), 3.16
(s, 3H, NCH3), 2.38 (t, J ¼ 7.2 Hz, 2H, CH2CO), 1.67e1.58 (m, 2H,
CH2), 1.22 (d, J ¼ 6.4 Hz, 6H, NOCH(CH3)2), 0.92 (t, J ¼ 7.2 Hz, 3H,
CH3). 13C NMR (CDCl3, 75 MHz):
d
176.3 (C]O), 75.6 (NOCH(CH3)2),
4.5.1. N-Methylcrotonamide (4a)
35.1 (NCH3), 34.2 (CH2CO), 20.8 (NOCH(CH3)2), 18.0 (CH2), 14.0
(CH3).
Colorless oil. IR spectrum (KBr, tablet): 3286, 3096, 2962,
1626 cmꢁ1. 1H NMR (CDCl3, 400 MHz):
d
6.80 (dq, J ¼ 15.2, 6.8 Hz,
1H, CH3CH]CHe), 5.76 (dq, J ¼ 15.2, 1.6 Hz, 1H, CH3CH]CHe), 5.52
(br s, NH, 1H), 2.79 (d, J ¼ 4.8 Hz, 3H, NCH3), 1.82 (dd, J ¼ 6.8, 1.6 Hz,
4.4. Preparation of N-hydroxyamides 1gei
3H, CH3). 13C NMR (CDCl3, 100 MHz):
d 166.7 (C]O), 139.6
A procedure for N-methyl-N-hydroxybutyramide (1g) is repre-
sentative. Et2O (12 mL) and water (6 mL) were added to the
(CH3CH]CHe), 124.9 (CH3CH]CHe), 26.2 (NCH3), 17.6 (CH3). MS
(EI) m/z 99 (Mþ).